<DOC>
	<DOCNO>NCT01222975</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics bioequivalence Risperidone formulation administration single dos normal , healthy subject fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions</brief_title>
	<detailed_description>A single dose two way crossover bioequivalence study 44 normal healthy male female utilized evaluate pharmacokinetics bioequivalence Risperidone ODT ( orally dissolve tablet ) formulation . The test product 1 mg ODT tablet formulation Risperidone manufacture Ranbaxy Laboratories Ltd . The reference product commercially available Risperidone 1 mg ODT tablet ( Risperdal® ) , Janssen Pharmaceutica Products , LP . Each single oral dose ( 1 mg ) administer orally 1 mg tablet . Blood sample collect interval 72-hour period medication administration . There washout period 14 day two period study .</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1 . Healthy subject least 18 year age 2 . Informed nature study give write informed consent 3 . Have body weight within 15 % appropriate range define 1983 Metropolitan Life Company table weigh least 110 pound 1 . Hypersensitivity risperidone ( Risperdal® ) 2 . Any history clinical condition might affect drug absorption , metabolism excretion 3 . Recent history ( within one year ) mental illness , drug addiction , drug abuse alcoholism 4 . Donation great 500 mg blood past 4 week prior study dose difficulty donate blood 5 . Received investigational drug within 4 week prior study dose 6 . Currently take prescription medication , except oral contraceptive , within 7 day prior study dose counter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication judge attend physician 7 . Regular smoke 5 cigarette daily daily use nicotinecontaining product begin 3 month study medication administration final evaluation 8 . If female subject lactate positive pregnancy test screen prior treatment period . Females childbearing potential must use medically acceptable method contraception throughout study period one week study complete . Medically acceptable method contraception may use subject and/ partner : oral contraceptive , progestin injection implant , condom spermicide , diaphragm spermicide , IUD , vaginal spermicidal suppository , surgical sterilization partner ( ) abstinence . Females take oral contraceptive must take consistently least three month prior receive study medication 9 . Alcohol , grapefruit beverage foods caffeine beverage foods begin 1 day study medication administration study confinement period . Such restricted item include coffee , tea , iced tea , coke® , Pepsi® , mountain dew® , chocolate , brownie , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>risperidone fasting study</keyword>
</DOC>